HPSE2
protein-codingheparanase 2 (inactive), the group of MicroRNA protein coding host genes|Heparanases
Gene summary
This gene encodes a heparanase enzyme. The encoded protein is a endoglycosidase that degrades heparin sulfate proteoglycans located on the extracellular matrix and cell surface. This protein may be involved in biological processes involving remodeling of the extracellular matrix including angiogenesis and tumor progression. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
- UFS
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~778.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0000463
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009368
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009368
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009368
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009368
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic; Renal
Intervention: Renal
Rationale: Individuals are at high risk of infantile-onset vesicoureteral reflux leading to kidney damage, hypertension, and eventual renal failure, and surveillance and preventive measures related to manifestations such as urinary tract/renal infections may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HPSE2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_021828.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 29 | 33 | |||
| missense | 1 | 142 | 5 | 1 | 149 | |
| nonsense | 3 | 2 | 1 | 6 | ||
| start loss | 0 | |||||
| frameshift | 3 | 7 | 10 | |||
| splice donor/acceptor (+/-2bp) | 2 | 4 | 1 | 7 | ||
| Total | 9 | 13 | 148 | 34 | 1 | 205 |
Highest pathogenic variant AF is 0.00041941786
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_068600.4 | 12 | MANE Select | |
| Ensembl | ENSP00000359583.3 | 12 | MANE Select | |
| RefSeq | NP_001159716.1 | 11 | Standard | |
| RefSeq | NP_001159717.1 | 10 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Proteoglycans in cancer - Homo sapiens (human)
- Glycosaminoglycan degradation - Homo sapiens (human)
- Metabolism of carbohydrates
- HS-GAG degradation
- Heparan sulfate/heparin (HS-GAG) metabolism
Biological Process
- glycosaminoglycan catabolic process
- biological_process
- positive regulation of cell population proliferation
- extracellular matrix organization
Molecular Function
- heparanase activity
- heparan sulfate proteoglycan binding
Cellular Component
- plasma membrane
- extracellular matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000370552
- Coding exons
- 12
- Length
- 776745
- Individuals with no LoFs
- 125670
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 78
- Defined
- 125748
- p
- 0.000310
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.245 | 316 | 329 | 0.962 | 0.0000189 | 3822 |
| Missense (PolyPhen) | 122 | 135.08 | 0.90319 | 1580 | ||
| Synonymous | -0.814 | 144 | 132 | 1.09 | 0.00000677 | 1224 |
| Loss of Function | 2.79 | 11 | 26.5 | 0.415 | 0.00000136 | 327 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00049 | 0.00049 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000095 | 0.000092 | rare |
| European (Non-Finnish) | 0.00052 | 0.00052 | rare |
| South Asian | 0.000065 | 0.000065 | rare |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Binds heparin and heparan sulfate with high affinity, but lacks heparanase activity. Inhibits HPSE, possibly by competing for its substrates (in vitro). {ECO:0000269|PubMed:20576607}.;
- Disease
- DISEASE: Urofacial syndrome 1 (UFS1) [MIM:236730]: A rare autosomal recessive disorder characterized by facial grimacing when attempting to smile and failure of the urinary bladder to void completely despite a lack of anatomical bladder outflow obstruction or overt neurological damage. Affected individuals often have reflux of infected urine from the bladder to the upper renal tract, with a risk of kidney damage and renal failure. {ECO:0000269|PubMed:20560209, ECO:0000269|PubMed:20560210}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.185
Intolerance Scores
- LoFtool
- 0.898
- RVIS EVS
- 0.09
- RVIS percentile EVS
- 60.57
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.303
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |